Clinical Overview
Isocarboxazid is a monoamine oxidase inhibitor (MAOI) indicated for the treatment of depression in patients who have not responded to other antidepressant therapies. As an irreversible, non-selective MAOI, it is typically reserved for treatment-resistant depression due to significant dietary restrictions and drug interactions.
Primary Clinical Applications
Isocarboxazid is indicated for depression that has not responded to other antidepressant classes. It may be particularly effective for atypical depression characterized by mood reactivity, hypersomnia, hyperphagia, and rejection sensitivity. MAOIs are considered when other treatments have failed.
Mechanism and Clinical Considerations
Isocarboxazid irreversibly inhibits both MAO-A and MAO-B enzymes, increasing levels of norepinephrine, serotonin, and dopamine. This broad mechanism may explain its efficacy in treatment-resistant cases but also accounts for its extensive interactions and dietary restrictions.
Safety and Monitoring Requirements
Treatment with isocarboxazid requires strict adherence to tyramine-restricted diet and careful monitoring for hypertensive crises. Patients must avoid numerous medications and foods high in tyramine. The irreversible nature of MAO inhibition means effects persist for weeks after discontinuation.
Prescribing Information
Dosing & Administration
Depression – Adults:
- Initial: 10 mg twice daily
- Titration: May increase by 10 mg every 2-4 days
- Effective dose: Usually 20-30 mg daily in divided doses
- Maximum: 60 mg daily (doses >40 mg/day require caution)
Elderly:
- Initial: 5-10 mg daily
- Titrate slowly with careful monitoring
Administration:
- Take with food to reduce GI upset
- Divide daily dose into 2-4 administrations
Indications
- Depression in patients who have not responded to other antidepressant therapy
- Typically reserved for treatment-resistant depression
Contraindications
- Hypersensitivity to isocarboxazid
- Concomitant use with other MAOIs, SSRIs, SNRIs, tricyclics
- Use with sympathomimetics, meperidine, dextromethorphan
- Pheochromocytoma
- Cardiovascular disease, cerebrovascular disease
- Severe renal or hepatic impairment
- History of headache or liver disease
Warnings & Precautions
- Boxed Warning: Increased risk of suicidal thoughts and behavior in patients under 25 years
- Hypertensive crisis: Risk with tyramine-containing foods and certain drugs
- Dietary restrictions: Avoid aged cheeses, cured meats, fermented foods, alcohol
- Drug interactions: Extensive list of contraindicated medications
- Withdrawal: Taper gradually to avoid discontinuation syndrome
Drug Interactions
- Antidepressants: Wait 14 days between MAOI and other antidepressants
- Sympathomimetics: Risk of hypertensive crisis
- Meperidine: Contraindicated – risk of serotonin syndrome
- Tyramine-rich foods: Hypertensive crisis risk
- Anesthetics: Discontinue 10 days before elective surgery
Adverse Reactions
Common:
- Orthostatic hypotension, dizziness, headache, drowsiness
- Dry mouth, constipation, nausea
Serious:
- Hypertensive crisis, hepatotoxicity, serotonin syndrome
Special Populations
- Elderly: Increased risk of orthostatic hypotension, start with lower doses
- Hepatic/Renal Impairment: Contraindicated in severe impairment
- Pregnancy: Category C – use only if clearly needed
- Dietary Education: Essential patient counseling on tyramine restrictions
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.
